文献速递外周动脉疾病

外周动脉疾病长期死亡与心血管事件性别差异的系统评价与meta分析

A systematic review and meta-analysis of gender differences in long-term mortality and cardiovascular events in peripheral artery disease.
PubMed 文献 · J Vasc Surg · 2020-11-06

该系统评价与meta分析检索PubMed和Embase 2000年至2019年1月的研究,最终分析14篇文章,比较症状性外周动脉疾病(PAD)患者长期死亡与主要不良心血管事件(MACE)的性别差异。结果显示男性全因死亡风险(HR 1.13;95%CI 1.10-1.16;P<.001)和MACE风险(HR 1.10;95%CI 1.06-1.14;P<.001)均高于女性。

要点

  • 男性PAD患者全因死亡风险高于女性(HR 1.13;95%CI 1.10-1.16)。
  • 男性PAD患者MACE风险高于女性(HR 1.10;95%CI 1.06-1.14)。
  • 间歇性跛行亚组男性死亡风险差异未达统计学意义(HR 1.13;95%CI 0.98-1.30;P=.09)。

核心结论

  • 男性PAD患者死亡与MACE风险高于女性,尽管存在其他公认的性别差异。
  • PAD患者结局性别差异的机制仍需进一步研究。

研究设计与样本

  • 系统评价与meta分析,检索PubMed和Embase 2000年至2019年1月的研究。
  • 共审阅13,582条文献,最终分析14篇文章,纳入年龄校正的死亡与MACE性别差异风险比(HR)。
  • 死亡结局按临床表现和研究情境进行分层。

主要发现

  • 男性全因死亡风险更高(HR 1.13;95%CI 1.10-1.16;P<.001)。
  • 男性MACE风险更高(HR 1.10;95%CI 1.06-1.14;P<.001)。
  • 危重症肢体缺血患者男性死亡风险更高(HR 1.08;95%CI 1.05-1.10;P<.001)。
  • 混合临床表现患者男性死亡风险更高(HR 1.16;95%CI 1.11-1.21;P<.001)。
  • 间歇性跛行患者男性死亡风险差异无统计学意义(HR 1.13;95%CI 0.98-1.30;P=.09)。

关键数值与推荐

  • 血运重建后男性死亡风险更高(HR 1.11;95%CI 1.04-1.19;P=.003)。
  • 住院患者男性死亡风险更高(HR 1.15;95%CI 1.08-1.22;P<.001)。
  • 截肢后男性死亡风险更高(HR 1.09;95%CI 1.08-1.10;P<.001)。
  • 门诊患者男性死亡风险差异无统计学意义(HR 1.13;95%CI 0.97-1.32;P=.13)。

临床怎么用

  • 评估男性PAD患者时应关注其较高的长期死亡与MACE风险。
  • 对血运重建后、住院及截肢后的男性患者应加强风险监测。

局限性

  • 纳入研究为观察性研究的汇总分析,性别差异机制未能明确。
  • 仅纳入报告年龄校正HR的研究,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Individual studies of peripheral artery disease (PAD) have indicated that gender discrepancies exist in the symptoms, functional status, and treatment usage. It remains uncertain whether these discrepancies result in different long-term outcomes. We examined the potential gender differences in mortality and major adverse cardiovascular events (MACE) in patients with symptomatic PAD. METHODS: The PubMed and Embase databases were searched for studies from 2000 to January 2019. After a review of 13,582 citations, 14 articles were analyzed. The reported age-adjusted hazard ratios (HRs) for gender differences in mortality and MACE were included in the meta-analysis. The mortality outcomes were stratified according to the clinical presentation and study context. RESULTS: Male gender was associated with a greater risk of all-cause mortality (HR, 1.13; 95% confidence interval [CI], 1.10-1.16; P < .001) and MACE (HR, 1.10; 95% CI, 1.06-1.14; P < .001). In a stratified analysis, male gender was associated with a higher mortality risk for patients presenting with either critical limb ischemia (HR, 1.08; 95% CI, 1.05-1.10; P < .001) or mixed clinical presentations (HR, 1.16; 95% CI, 1.11-1.21; P < .001) but not for those with intermittent claudication (HR, 1.13; 95% CI, 0.98-1.30; P = .09). Elevated mortality risk was evident after revascularization (HR, 1.11; 95% CI, 1.04-1.19; P = .003), hospitalization (HR, 1.15; 95% CI, 1.08-1.22; P < .001), and amputation (HR, 1.09; 95% CI, 1.08-1.10; P < .001), although not in outpatient clinics (HR, 1.13; 95% CI, 0.97-1.32; P = .13), in men compared with women. CONCLUSIONS: Greater mortality and MACE rates in men with PAD occurred despite other accepted gender disparities. The mechanisms underlying these gender differences in the outcomes for PAD patients require further investigation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Parvar SL, Thiyagarajah A, Nerlekar N, et al. A systematic review and meta-analysis of gender differences in long-term mortality and cardiovascular events in peripheral artery disease. J Vasc Surg. 2020. PMID: 33161072. doi:10.1016/j.jvs.2020.09.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。